Abstract：
OBJECTIVE: The study intends to evaluate the clinical outcome of treating young patients of unicystic ameloblastoma, by various conservative treatment modalities such as marsupialization, enucleation with bone curettage and aid in establishing sound treatment guidelines.
METHODS: A case series of fifteen patients is presented of unicystic ameloblastoma, who presented to our Department over the past 6 years (2010-2015) and conservative method of treatment elected in all the patients. Also, a methodical literature review of studies discussing treatment of unicystic ameloblastoma in young age group (<20 years) patients over the last 15 years from 2001 to 2015 is added.
RESULTS: Faster osseous regeneration after conservative treatment was noted, owing to the young age and growth potential. Over a mean follow-up of 4 years, uneventful secondary healing, no clinical or radiographic evidence of recurrence and no apparent deformity were noted in any of the cases.
CONCLUSIONS: Unicystic ameloblastoma is a benign, locally invasive odontogenic neoplasm of young age which can develop during the stage of tooth formation and hence its early inception and vast proliferation is not uncommon in this age group, due to which it can grow into a huge lesion causing significant morbidity. Conservative surgical management may be a viable option to reduce morbidity and increase the probability of uneventful secondary healing and bone regeneration in the younger population.
METHODS: A case series of fifteen patients is presented of unicystic ameloblastoma, who presented to our Department over the past 6 years (2010-2015) and conservative method of treatment elected in all the patients. Also, a methodical literature review of studies discussing treatment of unicystic ameloblastoma in young age group (<20 years) patients over the last 15 years from 2001 to 2015 is added.
RESULTS: Faster osseous regeneration after conservative treatment was noted, owing to the young age and growth potential. Over a mean follow-up of 4 years, uneventful secondary healing, no clinical or radiographic evidence of recurrence and no apparent deformity were noted in any of the cases.
CONCLUSIONS: Unicystic ameloblastoma is a benign, locally invasive odontogenic neoplasm of young age which can develop during the stage of tooth formation and hence its early inception and vast proliferation is not uncommon in this age group, due to which it can grow into a huge lesion causing significant morbidity. Conservative surgical management may be a viable option to reduce morbidity and increase the probability of uneventful secondary healing and bone regeneration in the younger population.
摘要：
目的：本研究旨在评估单囊性成釉细胞瘤年轻患者的临床疗效，通过各种保守治疗方式，如袋袋化，骨刮除术和帮助建立合理的治疗指南。
方法：有15例单囊性成釉细胞瘤患者，在过去的6年（2010-2015年）中，他向我们部门介绍了所有患者中选择的保守治疗方法。此外，增加了一项关于2001年至2015年过去15年中青年年龄组(<20岁)单囊性成釉细胞瘤治疗研究的系统文献综述.
结果：注意到保守治疗后骨再生更快，由于年轻和成长潜力。平均随访4年,顺利的二次愈合，在任何病例中均未发现复发的临床或影像学证据,也未发现明显的畸形.
结论：单囊性成釉细胞瘤是良性的，年轻的局部侵袭性牙源性肿瘤可以在牙齿形成阶段发展，因此它的早期开始和大量增殖在这个年龄段并不少见，因此，它可以长成一个巨大的病变，导致显著的发病率。保守性手术治疗可能是降低发病率并增加年轻人群中继发愈合和骨再生的可能性的可行选择。
方法：有15例单囊性成釉细胞瘤患者，在过去的6年（2010-2015年）中，他向我们部门介绍了所有患者中选择的保守治疗方法。此外，增加了一项关于2001年至2015年过去15年中青年年龄组(<20岁)单囊性成釉细胞瘤治疗研究的系统文献综述.
结果：注意到保守治疗后骨再生更快，由于年轻和成长潜力。平均随访4年,顺利的二次愈合，在任何病例中均未发现复发的临床或影像学证据,也未发现明显的畸形.
结论：单囊性成釉细胞瘤是良性的，年轻的局部侵袭性牙源性肿瘤可以在牙齿形成阶段发展，因此它的早期开始和大量增殖在这个年龄段并不少见，因此，它可以长成一个巨大的病变，导致显著的发病率。保守性手术治疗可能是降低发病率并增加年轻人群中继发愈合和骨再生的可能性的可行选择。
